Baxalta Alliance

Since 2009 3BP and Baxalta are running an R&D collaboration to develop novel innovative peptide therapeutics for hemophilia. Lead compounds for multiple targets have been developed.

Baxalta and 3BP. Search for innovative hemophilia treatments.Baxalta and 3BP. Search for innovative hemophilia treatments.